Asthma trials in Brazil

In Brazil 14 Also abroad 500

14 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Where
Brasília, Porto Alegre, Sorocaba
Age
6 years to 11 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Blumenau, Curitiba, Salvador, São Paulo, Sorocaba
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Blumenau, Porto Alegre, Salvador, Santo André, São Bernardo do Campo
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Where
Aracaju, Curitiba, Goiânia, Marília, Natal, Passo Fundo, Ribeirão Preto, Rio de Janeiro, Sorocaba
Age
18 years to 75 years
People
531 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07219173
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Caxias do Sul, Criciúma, Porto Alegre, Salvador, Santo André, São José do Rio Preto, São Paulo, Sorocaba
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Blumenau, Curitiba, Goiânia, Porto Alegre, Recife, Rio de Janeiro, Salvador, São Paulo
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Porto Alegre, São Paulo, Sorocaba
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
No phaseNot yet taking people in Brazil
Chronic Effects of Photobiomodulation With an LED Vest on Functional Capacity, Inflammatory Markers, and Muscle Perfusion in Children With Asthma
Where
São Paulo
Age
6 years to 17 years
People
60
Run by
University of Nove de Julho
See details and how to joinNCT07613671
No phaseNot yet taking people in Brazil
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity (MARES3)
Where
São Carlos, São Paulo
Age
30 years and over
People
473
Run by
University College, London
See details and how to joinNCT07134855
No phaseNot yet taking people in Brazil
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity
Where
São Carlos, São Paulo
Age
30 years and over
People
1,000
Run by
University College, London
See details and how to joinNCT07093021
No phaseTaking people
Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity
Where
São Carlos, São Paulo
Age
30 years and over
People
859
Run by
University College, London
See details and how to joinNCT07050823
No phaseTaking people
Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma
Where
São Paulo
Age
18 years to 65 years
People
56
Run by
University of Sao Paulo General Hospital
See details and how to joinNCT05364632
No phaseTaking people
Impact of Educational Intervention Protocol on the Level of Knowledge, Clinical Control and Lung Function of People With Asthma
Where
João Pessoa
Age
8 years and over
People
28
Run by
Federal University of Paraíba
See details and how to joinNCT06878352
No phaseTaking people
Effects of a Pulmonary and Cardiovascular Rehabilitation Program
Where
Campinas
Age
18 years and over
People
26
Run by
University of Campinas, Brazil
See details and how to joinNCT06772922